StockMacro
Menu

DocGo

$0.17 -72% in 6 monthsMarket cap $17.3M

DCGO on XNAS, Transportation, DocGo Inc., job postings

Measures activity, not value. Not investment advice.

Net loss reached $181.3M over 12 months as institutional holders fell 25%.

  • WatchLatest quarter revenue up 3.7% to $73.4M, but 12-month revenue down 19%
  • BadShares fell 72% in six months

Written by AI from the data on this page, 22 Nov 2026. Not investment advice.

Profile and fundamentals

From its SEC filings, 12 months to 30 Sep 2026

DocGo Inc is a provider of last-mile mobile health services and integrated medical mobility solutions. The company uses its care delivery platform to provide mobile health services, virtual care management, and ambulance services. It has two reporting segments: Mobile Health Services and Transportation Services. A majority of its revenue is generated from the Mobile Health Services segment, which includes various healthcare services performed at homes, offices, and other locations and event services such as on-site healthcare support at sporting events and concerts. Geographically, the company generates a majority of its revenue from the United States and the rest from the United Kingdom.

Industry
Transportation services (Transportation)
Employees
3,568
Website
docgo.com
Listed
Nasdaq, US
Last results
9 Nov 2026
Next results
expected around 15 Mar 2027 (an estimate: a year ago it reported on 16 Mar 2026)
Revenue and net income per quarter. Quarter to 30 Sep 2026: revenue $73.4M, net loss $16.6M.
Quarter to 31 Dec 2021: revenue $121.3M, net income $19.7MQuarter to 31 Dec 2021: revenue $121.3M, net income $19.7MQuarter to 31 Mar 2022: revenue $117.9M, net income $9.4MQuarter to 31 Mar 2022: revenue $117.9M, net income $9.4MQuarter to 30 Jun 2022: revenue $109.5M, net income $11.8MQuarter to 30 Jun 2022: revenue $109.5M, net income $11.8MQuarter to 30 Sep 2022: revenue $104.3M, net income $2.5MQuarter to 30 Sep 2022: revenue $104.3M, net income $2.5MQuarter to 31 Dec 2022: revenue $108.8M, net income –Quarter to 31 Mar 2023: revenue $113.0M, net income -$3.5MQuarter to 31 Mar 2023: revenue $113.0M, net income -$3.5MQuarter to 30 Jun 2023: revenue $125.5M, net income $1.3MQuarter to 30 Jun 2023: revenue $125.5M, net income $1.3MQuarter to 30 Sep 2023: revenue $186.6M, net income $4.6MQuarter to 30 Sep 2023: revenue $186.6M, net income $4.6MQuarter to 31 Dec 2023: revenue $199.2M, net income $8.0MQuarter to 31 Dec 2023: revenue $199.2M, net income $8.0MQuarter to 31 Mar 2024: revenue $192.1M, net income $10.6MQuarter to 31 Mar 2024: revenue $192.1M, net income $10.6MQuarter to 30 Jun 2024: revenue $164.9M, net income $5.9MQuarter to 30 Jun 2024: revenue $164.9M, net income $5.9MQuarter to 30 Sep 2024: revenue $138.7M, net income $4.5MQuarter to 30 Sep 2024: revenue $138.7M, net income $4.5MQuarter to 31 Dec 2024: revenue $120.8M, net income -$7.6MQuarter to 31 Dec 2024: revenue $120.8M, net income -$7.6MQuarter to 31 Mar 2025: revenue $96.0M, net income -$11.1MQuarter to 31 Mar 2025: revenue $96.0M, net income -$11.1MQuarter to 30 Jun 2025: revenue $80.4M, net income -$11.2MQuarter to 30 Jun 2025: revenue $80.4M, net income -$11.2MQuarter to 30 Sep 2025: revenue $70.8M, net income -$27.8MQuarter to 30 Sep 2025: revenue $70.8M, net income -$27.8MQuarter to 31 Dec 2025: revenue $74.9M, net income -$134.1MQuarter to 31 Dec 2025: revenue $74.9M, net income -$134.1MQuarter to 31 Mar 2026: revenue $75.6M, net income -$14.8MQuarter to 31 Mar 2026: revenue $75.6M, net income -$14.8MQuarter to 30 Jun 2026: revenue $73.4M, net income -$15.8MQuarter to 30 Jun 2026: revenue $73.4M, net income -$15.8MQuarter to 30 Sep 2026: revenue $73.4M, net income -$16.6MQuarter to 30 Sep 2026: revenue $73.4M, net income -$16.6M
31 Dec 2021RevenueNet incomeNet losstallest bar $199.2M30 Sep 2026
See the numbers
Quarter toRevenueNet income
30 Sep 2026$73.4M-$16.6M
30 Jun 2026$73.4M-$15.8M
31 Mar 2026$75.6M-$14.8M
31 Dec 2025$74.9M-$134.1M
30 Sep 2025$70.8M-$27.8M
30 Jun 2025$80.4M-$11.2M
31 Mar 2025$96.0M-$11.1M
31 Dec 2024$120.8M-$7.6M
30 Sep 2024$138.7M$4.5M
30 Jun 2024$164.9M$5.9M
31 Mar 2024$192.1M$10.6M
31 Dec 2023$199.2M$8.0M
30 Sep 2023$186.6M$4.6M
30 Jun 2023$125.5M$1.3M
31 Mar 2023$113.0M-$3.5M
31 Dec 2022$108.8M–
30 Sep 2022$104.3M$2.5M
30 Jun 2022$109.5M$11.8M
31 Mar 2022$117.9M$9.4M
31 Dec 2021$121.3M$19.7M
Fundamentals, 12 months to 30 Sep 2026
MeasureLatestYear beforePeer median
RevenueSales over the last 12 months reported. $297.3M $368.1M
Revenue growthRevenue of the last 12 months compared with the 12 months before. -19% +9.8%
Net incomeProfit after all costs and taxes over the last 12 months reported. Negative is a loss. -$181.3M -$56.0M
EPS (diluted)Earnings per share: net income divided by the shares, counting options and convertibles. Left blank when the figures as filed do not fit today's share count (after a split). -$1.83 -$0.52
Gross marginWhat is left of each dollar of sales after the direct cost of making the product or service. – – 18.7%
Operating marginOperating income as a share of sales: profit from the business before interest and taxes. -53.3% -22.0% 4.9%
Net marginNet income as a share of sales: what the owners keep of each dollar sold. -61.0% -15.2% 1.0%
Return on equityNet income of the last 12 months divided by shareholders' equity (the average of the latest balance sheet and the one a year earlier): the profit made on the owners' money. -96.5% -5.7%
Free cash flowCash from operations minus capital spending over the last 12 months: cash the business produced. – –
CashCash, cash equivalents and short-term investments on the latest balance sheet. $19.1M $73.4M
DebtShort- and long-term borrowings on the latest balance sheet. Operating leases are not counted. – –
Net debtDebt minus cash. Negative means the company holds more cash than it owes (net cash). – –
Debt to equityDebt divided by shareholders' equity on the latest balance sheet: how much is borrowed for each dollar the owners have in the company. Blank when equity is negative. – 1.3
Book value per shareShareholders' equity (assets minus liabilities) on the latest balance sheet divided by the shares outstanding. $1.06
P/EPrice to earnings: market cap divided by net income of the last 12 months. What investors pay for one dollar of yearly profit. Blank when the company made a loss. loss 16.0
P/SPrice to sales: market cap divided by revenue of the last 12 months. 0.06 2.0
EV/SalesEnterprise value (market cap plus debt minus cash) divided by revenue of the last 12 months. – 2.7
P/BPrice to book: market cap divided by shareholders' equity on the latest balance sheet. Blank when equity is negative. 0.16 1.7

Latest = 12 months to 30 Sep 2026; balance-sheet lines at its end. Peer median: companies in the same industry (SIC code), or the sector when the industry is small.

Peers nearest by market cap, its own industry first

CompanyMarket capP/EP/SRevenue growthNet margin
DocGoDCGO (this company) $17.3Mloss0.06-19%-61.0%
NextTripNTRP $10.6Mloss2.2+357%-320%
Proficient Auto LogisticsPAL $76.6Mloss–––
Virgin GalacticSPCE $157.7Mloss143-34%–
Verra MobilityVRRM $243.2M6.40.24+6.5%3.8%
Odyssey Marine ExplorationOMEX $15.0Mloss64.7-50%–

Insider Buy/Sell Shares the company's insiders (directors, officers and owners of 10% or more) bought minus what they sold on the open market in the last 90 days, from their Form 4 filings.

–

No data for this company

Institutional holders The number of institutional investment managers (13F filers: funds, pensions, asset managers) reporting the stock, compared with the quarter before. 13F reports are public 45 days after quarter end and show long positions only.

-25%

87 13F filers vs 116

Institutional ownership Shares held by 13F filers at the latest quarter end, divided by the shares outstanding in the company's latest filing. Above 100% usually means a stale share count or double counting, and is marked.

31%

30.4M shares held by 13F filers (30 Sep 2026) of 99.0M outstanding (5 Nov 2026)

Short interest Shares sold short and not yet bought back, divided by the shares outstanding in the company's latest filing. From FINRA's latest short interest report: FINRA reports twice a month and publishes 7 business days after the settlement date. Above 100% means a stale share count, and is marked.

2.2%

2.1M shares sold short (30 Oct 2026) of 99.0M outstanding (5 Nov 2026)

Days to cover Short interest divided by the stock's average daily trading volume, as FINRA publishes it: how many days of normal trading it would take short sellers to buy back every share. Latest report.

3.9

2.1M shares sold short (30 Oct 2026) divided by the stock's average daily volume, as FINRA publishes it

Short interest change How the number of shares sold short changed between FINRA's two latest reports, about two weeks apart.

+7.9%

2.0M shares sold short in the report before, 2.1M on 30 Oct 2026

Short sale volume Share of the stock's latest daily volume on FINRA-reported off-exchange venues that was sold short. Market makers sell short routinely, so 40% to 50% is normal; compare it with the company's own 1-year average in the cell's details. A daily flow, not short interest.

28%

28% of off-exchange volume on 20 Nov 2026 was short sales; 1-year average 51%

Open jobs Job postings open on the company's own careers site today, where we track it. Blank when we do not track this company's careers site yet.

–

We do not track this company's careers site yet.

Open jobs change How the number of open job postings changed over the last 30 days: total hiring demand, any job, any country. Shown only once we have tracked the company for 30 days.

–

We do not track this company's careers site yet.

Employees Total staff the company reported in its latest annual report (10-K), with the change from the year before when both years are reported.

–

No headcount in its annual reports in our data.

Visa hiring (foreign workers) Applications to hire foreign specialists on H-1B and E-3 visas certified by the Labor Department in the last 12 months, compared with the 12 months before. This is NOT total hiring: most hires need no visa. Open jobs shows total hiring where we track it.

–

No data for this company

Revenue growth Sales in the latest reported quarter compared with the same quarter a year earlier.

+3.7%

$73.4M vs $70.8M (quarter ended 30 Sep 2026)

Capital spending Money spent on buildings, machines and equipment in the latest quarter, compared with the same quarter a year earlier.

–

No data for this company

Federal contracts Money the US government committed to the company in contracts and grants over the last 12 months.

–

No data for this company

Lobbying What the company reported spending on federal lobbying over the last four quarters.

$20K

4 quarters, $

Layoff notices Workers named in state WARN layoff notices over the last 12 months (employers must file them 60 days before a large layoff).

–

No data for this company

News (7d) Articles about the company published in the last 7 days, from our Google News collection (one search per company, every half hour). Blank when we do not collect news for this company.

0

0 articles in the last 7 days; its usual week has 0 (the median of the 26 weeks before).

News vs usual Articles in the last 7 days divided by the company's usual week: the median week of the 26 weeks before. Blank when the usual week has fewer than one article.

–

0 articles in the last 7 days; its usual week has 0: fewer than one, so there is nothing to compare with.

Price $0.17 on 20 Nov 2026, -80% over 12 months (12-month range $0.17 to $1.08)

  • Sharp change
  • 8-K and other filings
  • Lobbying filing
Insider net buying (open market). Insiders sold a net $15K in the last 12 months (the 12 months before: -$57K).
Revenue per quarter. Revenue $73.4M in the latest quarter, +3.7% on a year earlier.
Capital spending per quarter. Capital spending $121K in the latest quarter.
Institutional holders (13F filers). 87 13F filers reported holding it in the latest 13F quarter, -24% on a year earlier.
Lobbying spend. Lobbying spend: $20K published in the last 12 months, -50% on the 12 months before.

Every point sits on the day the fact became public (filing acceptance or publication), not the day it happened; prices through 20 Nov 2026. Hover or tap a marker for the fact; click it for the evidence or the source. No data here for: h-1b/e-3 applications certified, federal obligations, workers in warn layoff notices.

See the numbers
Dated facts on the price chart (newest 100)
Became publicKindFact
13 Nov 20268-K and other filingsCEO Lee Bienstock entered transition agreement through Mar 31, 2027 with $785,000 severance; successor CEO search ongoing
13 Nov 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
5 Oct 20268-K and other filingsA major agreement ended
10 Aug 20268-K and other filingsReport will be filed late
31 Jul 20268-K and other filingsDelisting notice or listing transfer
22 Apr 20268-K and other filingsDirector or officer change
22 Apr 2026Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
20 Apr 2026Lobbying filinglobbying engagement terminated (FOLEY & LARDNER LLP)
30 Jan 20268-K and other filingsDelisting notice or listing transfer
16 May 2025Sharp changeClustered insider buying: clustered insider buying (5 independent filers, 5 filing(s) in 30 days, value_usd total 103K)
30 Sep 20248-K and other filingsDirector or officer change
30 Sep 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
14 May 2024Sharp changeQuarterly revenue change: quarterly revenue change, 192.1M vs usual 115.4M (2024-03-31); 1.7x the same period a year earlier
19 Mar 2024Sharp changeClustered insider buying: clustered insider buying (3 independent filers, 3 filing(s) in 30 days, value_usd total 121K)
8 Mar 20248-K and other filingsDirector or officer change
8 Mar 2024Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
5 Mar 2024Sharp changeQuarterly revenue change: quarterly revenue change, 199.2M vs usual 115.4M (2023-12-31); 1.8x the same period a year earlier
7 Nov 2023Sharp changeQuarterly revenue change: quarterly revenue change, 186.6M vs usual 111.3M (2023-09-30); 1.8x the same period a year earlier
13 Oct 20238-K and other filingsDirector or officer change
15 Sep 20238-K and other filingsDirector or officer change
15 Sep 2023Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
29 Dec 20228-K and other filingsDirector or officer change
14 Nov 20228-K and other filingsDirector or officer change
7 Nov 20228-K and other filingsDirector or officer change
7 Nov 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
4 Apr 20228-K and other filingsDirector or officer change
14 Mar 20228-K and other filingsDirector or officer change
14 Mar 2022Sharp changeDirector or officer change (8-K item 5.02): director or officer change (8-K item 5.02) (1 event(s) in 90 days)
15 Dec 20218-K and other filingsRegistered new securities for sale (S-1)
24 Nov 20218-K and other filingsRegistered new securities for sale (S-1)
23 Nov 20218-K and other filingsEarlier financial statements can no longer be relied on
Insider net buying (open market)
Month from 1 May 2023: -$1.5M published
Month from 1 Jun 2023: -$785K published
Month from 1 Aug 2023: -$1.6M published
Month from 1 Sep 2023: -$88K published
Month from 1 Oct 2023: -$63K published
Month from 1 Nov 2023: -$16K published
Month from 1 Mar 2024: $121K published
Month from 1 May 2024: $144K published
Month from 1 Dec 2024: -$174K published
Month from 1 May 2025: $117K published
Month from 1 Dec 2025: -$15K published
Revenue per quarter
Quarter ended 31 Mar 2021: $49.7M; public on 11 May 2022
Quarter ended 30 Jun 2021: $62.2M; public on 10 Aug 2022
Quarter ended 30 Sep 2021: $85.8M; public on 9 Nov 2022
Quarter ended 31 Dec 2021: $121.3M; public on 16 Mar 2022
Quarter ended 31 Mar 2022: $117.9M, +137% on a year earlier; public on 11 May 2022
Quarter ended 30 Jun 2022: $109.5M, +76% on a year earlier; public on 10 Aug 2022
Quarter ended 30 Sep 2022: $104.3M, +22% on a year earlier; public on 9 Nov 2022
Quarter ended 31 Dec 2022: $108.8M, -10% on a year earlier; public on 15 Mar 2023
Quarter ended 31 Mar 2023: $113.0M, -4.1% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $125.5M, +15% on a year earlier; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $186.6M, +79% on a year earlier; public on 7 Nov 2023
Quarter ended 31 Dec 2023: $199.2M, +83% on a year earlier; public on 29 Feb 2024
Quarter ended 31 Mar 2024: $192.1M, +70% on a year earlier; public on 9 May 2024
Quarter ended 30 Jun 2024: $164.9M, +31% on a year earlier; public on 8 Aug 2024
Quarter ended 30 Sep 2024: $138.7M, -26% on a year earlier; public on 8 Nov 2024
Quarter ended 31 Dec 2024: $120.8M, -39% on a year earlier; public on 28 Feb 2025
Quarter ended 31 Mar 2025: $96.0M, -50% on a year earlier; public on 9 May 2025
Quarter ended 30 Jun 2025: $80.4M, -51% on a year earlier; public on 8 Aug 2025
Quarter ended 30 Sep 2025: $70.8M, -49% on a year earlier; public on 11 Nov 2025
Quarter ended 31 Dec 2025: $74.9M, -38% on a year earlier; public on 17 Mar 2026
Quarter ended 31 Mar 2026: $75.6M, -21% on a year earlier; public on 12 May 2026
Quarter ended 30 Jun 2026: $73.4M, -8.7% on a year earlier; public on 18 Aug 2026
Quarter ended 30 Sep 2026: $73.4M, +3.7% on a year earlier; public on 10 Nov 2026
Capital spending per quarter
Quarter ended 31 Mar 2021: $760K; public on 11 May 2022
Quarter ended 30 Jun 2021: $1.8M; public on 10 Aug 2022
Quarter ended 30 Sep 2021: $243K; public on 9 Nov 2022
Quarter ended 31 Dec 2021: $2.0M; public on 16 Mar 2022
Quarter ended 31 Mar 2022: $602K, -21% on a year earlier; public on 11 May 2022
Quarter ended 31 Dec 2022: $1.2M, -39% on a year earlier; public on 15 Mar 2023
Quarter ended 31 Mar 2023: $2.0M, +228% on a year earlier; public on 10 May 2023
Quarter ended 30 Jun 2023: $4.8M; public on 9 Aug 2023
Quarter ended 30 Sep 2023: $5.5M; public on 7 Nov 2023
Quarter ended 31 Dec 2023: $3.2M, +168% on a year earlier; public on 29 Feb 2024
Quarter ended 31 Mar 2024: $952K, -52% on a year earlier; public on 9 May 2024
Quarter ended 31 Dec 2024: $893K, -72% on a year earlier; public on 28 Feb 2025
Quarter ended 31 Mar 2025: $1.5M, +54% on a year earlier; public on 9 May 2025
Quarter ended 31 Mar 2026: $430K, -71% on a year earlier; public on 12 May 2026
Quarter ended 30 Jun 2026: $321K; public on 18 Aug 2026
Quarter ended 30 Sep 2026: $121K; public on 10 Nov 2026
Institutional holders (13F filers)
31 Dec 2021 report: 45; public on 14 Feb 2022
31 Mar 2022 report: 66; public on 16 May 2022
30 Jun 2022 report: 85; public on 15 Aug 2022
30 Sep 2022 report: 109; public on 14 Nov 2022
31 Dec 2022 report: 121; public on 14 Feb 2023
31 Mar 2023 report: 137; public on 15 May 2023
30 Jun 2023 report: 134; public on 14 Aug 2023
30 Sep 2023 report: 127; public on 14 Nov 2023
31 Dec 2023 report: 133; public on 14 Feb 2024
31 Mar 2024 report: 131; public on 15 May 2024
30 Jun 2024 report: 119; public on 14 Aug 2024
30 Sep 2024 report: 123; public on 14 Nov 2024
31 Dec 2024 report: 128; public on 14 Feb 2025
31 Mar 2025 report: 131; public on 15 May 2025
30 Jun 2025 report: 116; public on 14 Aug 2025
30 Sep 2025 report: 114; public on 14 Nov 2025
31 Dec 2025 report: 108; public on 17 Feb 2026
31 Mar 2026 report: 118; public on 15 May 2026
30 Jun 2026 report: 116; public on 14 Aug 2026
30 Sep 2026 report: 87; public on 16 Nov 2026
Lobbying spend
Quarter from 1 Jan 2022: $10K published
Quarter from 1 Apr 2022: $10K published
Quarter from 1 Jul 2022: $10K published
Quarter from 1 Oct 2022: $10K published
Quarter from 1 Jan 2023: $10K published
Quarter from 1 Apr 2023: $10K published
Quarter from 1 Jul 2023: $10K published
Quarter from 1 Oct 2023: $10K published
Quarter from 1 Jan 2024: $10K published
Quarter from 1 Apr 2024: $10K published
Quarter from 1 Jul 2024: $10K published
Quarter from 1 Oct 2024: $10K published
Quarter from 1 Jan 2025: $10K published
Quarter from 1 Apr 2025: $10K published
Quarter from 1 Jul 2025: $10K published
Quarter from 1 Oct 2025: $10K published
Quarter from 1 Jan 2026: $10K published
Quarter from 1 Apr 2026: $10K published

What is unusual now

  • Nothing unusual in the last 90 days: no change appeared. Its most unusual measure now is insider open-market selling (USD, Form 4) at $15K (16 Dec 2025), higher than 41% of its own history.
  • Insider net buying (open market): Insiders sold a net $15K in the last 12 months (the 12 months before: -$57K).
  • Revenue per quarter: Revenue $73.4M in the latest quarter, +3.7% on a year earlier.
  • Capital spending per quarter: Capital spending $121K in the latest quarter.

Latest records

The names and amounts behind the totals, newest first

Insider trades

All 29 insider trades

No trades in the last 90 days; the latest was filed 16 Dec 2025. Open-market trades by officers, directors and 10% owners.

FiledInsiderTradeSharesPriceValueSource
16 Dec 2025Ely D TendlerGeneral Counsel and SecretarySell16,850$0.91$15KForm 4
23 May 2025Michael J BurdiekDirectorBuy10,000$1.33$13KForm 4
15 May 2025Michael J BurdiekDirectorBuy15,000$1.43$21KForm 4
14 May 2025Stephen K. Klasko M.d.DirectorBuy15,000$1.49$22KForm 4
14 May 2025Stephen SugrueChief Compliance OfficerBuy10,000$1.44$14KForm 4
14 May 2025Lee BienstockChief Executive OfficerBuy15,000$1.54$23KForm 4
14 May 2025Norman RosenbergCFO and TreasurerBuy15,000$1.47$22KForm 4
17 Dec 2024Etalvina LeiteDirectorSell16,500$4.34$72KForm 4

87 institutions reported shares at the end of Q3 2026, 31% of the shares outstanding; 4 opened a position, 31 sold out. From 13F reports.

InstitutionShares% of companyValueChange vs Q2 2026
Vanguard Capital Management LLC3.9M3.94%$1.6M+168K+4.5%
P.A.W. Capital Corp3.8M3.79%$1.5MNo change
Knott David M Jr2.7M2.70%$1.1MNo change
S Squared Technology, LLC2.1M2.08%$822KNo change
Renaissance Technologies LLC2.0M1.99%$788K-284K-13%
Acadian Asset Management LLC1.7M1.76%-48K-2.7%
Moore Capital Management, LP1.5M1.48%$586KNo change
Gsa Capital Partners LLP1.4M1.46%+439K+44%
BlackRock, Inc.1.4M1.41%$557K-60K-4.1%
Isthmus Partners, LLC1.2M1.22%$481K+12K+1.0%

Company events

All 36 company events

In 12 months: 2 delisting notices, 2 director or officer changes, 2 major agreements, 1 late report. Results releases and routine reports are left out.

FiledWhat happenedSource
13 Nov 2026CEO Lee Bienstock entered transition agreement through Mar 31, 2027 with $785,000 severance; successor CEO search ongoing8-K
5 Oct 2026Signed a major agreement; A major agreement endedSame filing: took on new debt, sold shares privately8-K
17 Aug 2026Signed a major agreement8-K
10 Aug 2026Quarterly report will be filed lateNT 10-Q
31 Jul 2026Delisting notice or listing transfer8-K
21 Apr 2026Director or officer change8-K
30 Jan 2026Delisting notice or listing transfer8-K
20 Oct 2025Signed a major agreement8-K

Reported lobbying spend: $10K in Q1 2026, $10K in Q4 2025. Rows are lobbying firms hired or let go; amounts are reported per quarter, not per firm here.

DateChangeLobbying firmIssueSource
31 Mar 2026EndedFoley & Lardner LLPfor Cardiac RMSRemote Cardiac MonitoringMEDFiling
1 Oct 2020EndedBGR Government Affairsfor AmbulnzNot statedFiling
14 Apr 2020NewBGR Government Affairsfor AmbulnzCARES Act funding and loan programsFinancial institutions, Health issuesFiling
26 Mar 2020NewFoley & Lardner LLPfor Cardiac RMSCOVID-19Health issuesFiling

The 5 newest of 55 articles that name the company.

Timeline

Several things at once

Two or more unrelated kinds of records unusual within 30 days

19 Mar 2024confirmed

Confirmed across sources Insiders and Filings + Financials

DocGo (DCGO): reported revenue of $199.2M for the quarter ended 31 Dec 2023, 1.8× the same quarter last year, while it had 3 insiders buy $121K of its shares on the open market within 30 days (3 filings). Two unrelated kinds of activity within 13 days.

  • Financials: Quarterly revenue change, became public on 5 Mar 2024
  • Insiders: Clustered insider buying, became public on 19 Mar 2024
2021-12-31: $121.3M2022-03-31: $117.9M2022-06-30: $109.5M2022-09-30: $104.3M2022-12-31: $108.8M2023-03-31: $113.0M2023-06-30: $125.5M2023-09-30: $186.6M2023-12-31: $199.2M
The quarter ended 31 Dec 2023 against the 8 quarters before it. this quarterearliernormal: $115.4M
See the evidence (2 changes)

Financials: Quarterly revenue change became public on 5 Mar 2024

DocGo reported revenue of $199.2M for the quarter ended 31 Dec 2023, 1.8× the same quarter last year.

This period
$199.2M (the quarter ended 31 Dec 2023)
Normal quarter (median of 8 earlier)
$115.4M
Typical spread (median absolute deviation)
$6.3M
How far from its usual level
+7.3
Same quarter last year
$108.8M
History used
1,005 days
2021-12-31: $121.3M2022-03-31: $117.9M2022-06-30: $109.5M2022-09-30: $104.3M2022-12-31: $108.8M2023-03-31: $113.0M2023-06-30: $125.5M2023-09-30: $186.6M2023-12-31: $199.2M
the quarter ended 31 Dec 20238 earlier quartersnormal: $115.4M

Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

Check it at the source: SEC EDGAR quarterly reports.

Insiders: Clustered insider buying became public on 19 Mar 2024

DocGo had 3 insiders buy $121K of its shares on the open market within 30 days (3 filings).

Independent buyers
3
Purchase filings (Form 4, code P)
3
Total bought
$121K
Window
18 Feb 2024 to 19 Mar 2024

Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

Timeline

Changes and notable records, by the date each became public

  1. 13 Nov 2026Filings change

    filed a director or officer change: CEO Lee Bienstock entered transition agreement through Mar 31, 2027 with $785,000 severance; successor CEO search ongoing.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  2. 13 Nov 2026Filings record

    CEO Lee Bienstock entered transition agreement through Mar 31, 2027 with $785,000 severance; successor CEO search ongoing

  3. 5 Oct 2026Filings record

    A major agreement ended

  4. 10 Aug 2026Filings record

    Report will be filed late

  5. 31 Jul 2026Filings record

    Delisting notice or listing transfer

  6. 22 Apr 2026Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  7. 22 Apr 2026Filings record

    Director or officer change (dated 21 Apr 2026)

  8. 20 Apr 2026Lobbying record

    CARDIAC RMS: lobbying engagement terminated (FOLEY & LARDNER LLP) (dated 31 Mar 2026)

  9. 30 Jan 2026Filings record

    Delisting notice or listing transfer

  10. 24 May 2025Insiders record

    Burdiek Michael J (director) bought 10,000 shares of DCGO ($13,300) (dated 23 May 2025)

  11. 16 May 2025Insiders change

    had 5 insiders buy $103K of its shares on the open market within 30 days (5 filings).

    Who bought: Rosenberg Norman, Bienstock Lee, Sugrue Stephen, Klasko Stephen K. M.D. and 1 more.

    See the evidence (5 source records)
    Independent buyers
    5
    Purchase filings (Form 4, code P)
    5
    Total bought
    $103K
    Window
    16 Apr 2025 to 16 May 2025

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  12. 16 May 2025Insiders record

    Burdiek Michael J (director) bought 15,000 shares of DCGO ($21,450) (dated 15 May 2025)

  13. 15 May 2025Insiders record

    Klasko Stephen K. M.D. (director) bought 15,000 shares of DCGO ($22,350) (dated 14 May 2025)

  14. 15 May 2025Insiders record

    Sugrue Stephen (Chief Compliance Officer) bought 10,000 shares of DCGO ($14,400) (dated 14 May 2025)

  15. 15 May 2025Insiders record

    Bienstock Lee (Chief Executive Officer) bought 15,000 shares of DCGO ($23,100) (dated 14 May 2025)

  16. 15 May 2025Insiders record

    ROSENBERG NORMAN (CFO and Treasurer) bought 15,000 shares of DCGO ($22,050) (dated 14 May 2025)

  17. 30 Sep 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  18. 30 Sep 2024Filings record

    Director or officer change

  19. 15 May 2024Insiders record

    Burdiek Michael J (director) bought 10,000 shares of DCGO ($34,000) (dated 14 May 2024)

  20. 14 May 2024Financials change

    reported revenue of $192.1M for the quarter ended 31 Mar 2024, 1.7× the same quarter last year.

    Same quarter last year: $113.0M; its normal quarter is $115.4M.

    See the evidence
    This period
    $192.1M (the quarter ended 31 Mar 2024)
    Normal quarter (median of 8 earlier)
    $115.4M
    Typical spread (median absolute deviation)
    $8.4M
    How far from its usual level
    +6.2
    Same quarter last year
    $113.0M
    History used
    1,096 days
    2022-03-31: $117.9M2022-06-30: $109.5M2022-09-30: $104.3M2022-12-31: $108.8M2023-03-31: $113.0M2023-06-30: $125.5M2023-09-30: $186.6M2023-12-31: $199.2M2024-03-31: $192.1M
    the quarter ended 31 Mar 20248 earlier quartersnormal: $115.4M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  21. 14 May 2024Insiders record

    Bienstock Lee (Chief Executive Officer) bought 25,000 shares of DCGO ($78,750) (dated 13 May 2024)

  22. 14 May 2024Insiders record

    Tendler Ely D (General Counsel and Secretary) bought 10,000 shares of DCGO ($31,300) (dated 13 May 2024)

  23. 19 Mar 2024several at once

    reported revenue of $199.2M for the quarter ended 31 Dec 2023, 1.8× the same quarter last year, while it had 3 insiders buy $121K of its shares on the open market within 30 days (3 filings). Two unrelated kinds of activity within 13 days.

    See the evidence (2 changes)

    Financials: Quarterly revenue change became public on 5 Mar 2024

    DocGo reported revenue of $199.2M for the quarter ended 31 Dec 2023, 1.8× the same quarter last year.

    This period
    $199.2M (the quarter ended 31 Dec 2023)
    Normal quarter (median of 8 earlier)
    $115.4M
    Typical spread (median absolute deviation)
    $6.3M
    How far from its usual level
    +7.3
    Same quarter last year
    $108.8M
    History used
    1,005 days
    2021-12-31: $121.3M2022-03-31: $117.9M2022-06-30: $109.5M2022-09-30: $104.3M2022-12-31: $108.8M2023-03-31: $113.0M2023-06-30: $125.5M2023-09-30: $186.6M2023-12-31: $199.2M
    the quarter ended 31 Dec 20238 earlier quartersnormal: $115.4M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

    Insiders: Clustered insider buying became public on 19 Mar 2024

    DocGo had 3 insiders buy $121K of its shares on the open market within 30 days (3 filings).

    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $121K
    Window
    18 Feb 2024 to 19 Mar 2024

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

    Several things at once means two or more unrelated kinds of records changed sharply within 30 days. Records that come from the same documents (for example filings and the financials taken from them) count as one kind.

  24. 19 Mar 2024Insiders change

    had 3 insiders buy $121K of its shares on the open market within 30 days (3 filings).

    Who bought: Burdiek Michael J, Rosenberg Norman, Katz Steven.

    See the evidence (3 source records)
    Independent buyers
    3
    Purchase filings (Form 4, code P)
    3
    Total bought
    $121K
    Window
    18 Feb 2024 to 19 Mar 2024

    Fires when at least 3 independent insiders (joint filers count once) buy on the open market in 30 days, in at least 2 filings, for $100K or more in total; amendments do not count.

  25. 19 Mar 2024Insiders record

    KATZ STEVEN (director) bought 13,500 shares of DCGO ($49,140) (dated 18 Mar 2024)

  26. 19 Mar 2024Insiders record

    ROSENBERG NORMAN (CFO and Treasurer) bought 10,000 shares of DCGO ($36,100) (dated 18 Mar 2024)

  27. 15 Mar 2024Insiders record

    Burdiek Michael J (director) bought 10,000 shares of DCGO ($36,100) (dated 14 Mar 2024)

  28. 8 Mar 2024Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  29. 8 Mar 2024Filings record

    Director or officer change

  30. 5 Mar 2024Financials change

    reported revenue of $199.2M for the quarter ended 31 Dec 2023, 1.8× the same quarter last year.

    Same quarter last year: $108.8M; its normal quarter is $115.4M.

    See the evidence
    This period
    $199.2M (the quarter ended 31 Dec 2023)
    Normal quarter (median of 8 earlier)
    $115.4M
    Typical spread (median absolute deviation)
    $6.3M
    How far from its usual level
    +7.3
    Same quarter last year
    $108.8M
    History used
    1,005 days
    2021-12-31: $121.3M2022-03-31: $117.9M2022-06-30: $109.5M2022-09-30: $104.3M2022-12-31: $108.8M2023-03-31: $113.0M2023-06-30: $125.5M2023-09-30: $186.6M2023-12-31: $199.2M
    the quarter ended 31 Dec 20238 earlier quartersnormal: $115.4M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  31. 7 Nov 2023Financials change

    reported revenue of $186.6M for the quarter ended 30 Sep 2023, 1.8× the same quarter last year.

    Same quarter last year: $104.3M; its normal quarter is $111.3M.

    See the evidence
    This period
    $186.6M (the quarter ended 30 Sep 2023)
    Normal quarter (median of 8 earlier)
    $111.3M
    Typical spread (median absolute deviation)
    $6.8M
    How far from its usual level
    +6.8
    Same quarter last year
    $104.3M
    History used
    913 days
    2021-09-30: $85.8M2021-12-31: $121.3M2022-03-31: $117.9M2022-06-30: $109.5M2022-09-30: $104.3M2022-12-31: $108.8M2023-03-31: $113.0M2023-06-30: $125.5M2023-09-30: $186.6M
    the quarter ended 30 Sep 20238 earlier quartersnormal: $111.3M

    Fires when the period is at least 3.0 robust standard deviations above the company's own median, with 6+ earlier periods, 540+ days of history and a value of at least $10.0M.

    Check it at the source: SEC EDGAR quarterly reports.

  32. 13 Oct 2023Filings record

    Director or officer change

  33. 15 Sep 2023Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  34. 15 Sep 2023Filings record

    Director or officer change

  35. 29 Dec 2022Filings record

    Director or officer change

  36. 14 Nov 2022Filings record

    Director or officer change

  37. 7 Nov 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

  38. 7 Nov 2022Filings record

    Director or officer change

  39. 4 Apr 2022Filings record

    Director or officer change

  40. 14 Mar 2022Filings change

    filed a director or officer change (8-K item 5.02), its first in 90 days.

    Item 5.02 covers departures and appointments alike, so this never counts toward a “several things at once”.

    See the evidence (1 source record)
    Filings in the window
    1

    Fires on an 8-K with item 5.02 after 90 days without one.

Showing the newest 40 of 59 entries; narrow the window or the kind of data to see older ones.

Not listed: 80 routine records (quarterly and annual reports, results releases, other 8-K items, material agreements and individual insider sales), counted over all history.

Identifiers and sources

How records are matched to this company, and what each source holds for it

Cik
0001822359
Ticker
DCGO
Domain
docgo.com
Hq location
NY|NEW YORK|10017 (1 unverified)
Lobbying client
cardiac rms
Name
AF DE LNZ LLC, AF WI, LLC, AF WI LNZ, LLC, Ambulnz AL, LLC and 54 more
Wikipedia
DocGo
  • Federal lobbying disclosures (LDA)4 records, 74 data points26 Mar 2020 to 31 Mar 2026
  • SEC Form 13F institutional holdings189 data points30 Sep 2021 to 30 Sep 2026
  • SEC EDGAR filings (8-K items, S-1, Form D, 10-K/10-Q)90 records25 Sep 2020 to 13 Nov 2026
  • SEC XBRL company facts (revenue, capex, R&D, backlog...)322 data points31 Dec 2019 to 5 Nov 2026
  • SEC Form 4 insider transactions29 records, 88 data points18 May 2023 to 16 Dec 2025
  • FINRA short interest (twice monthly)357 data points15 Nov 2021 to 30 Oct 2026
  • FINRA daily short sale volume (off-exchange)2530 data points8 Nov 2021 to 20 Nov 2026
  • Wikipedia pageviews11 data points11 Nov 2026 to 21 Nov 2026